DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

167.91 -1.26 (-0.74%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $167.91 -0.74%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $168.15
Previous Close $169.17
Daily Range $166.06 - $169.25
52-Week Range $108.20 - $173.60
Market Cap $127.4B
P/E Ratio 23.14
Dividend (Yield) $3.16 (1.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,548,265
Average Daily Volume 3,449,421
Current FY EPS $9.47




Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

Illumina's Earnings Set Positive Tone for Biotech

What's behind Illumina's remarkable earnings beat, and what could it mean for biotech stocks?

Nasdaq Joins The Record High Club

Insider Trading Alert - KMG, MPWR And AMGN Traded By Insiders

Next Week In Biotech: Gilead, Celgene Report; PDUFAs For Theravance, The Medicines Co. Daily Round Up 4/23/15: GE, OMN, COCP, AGCO

The Zacks Analyst Blog Highlights: Amgen, Medicines, Athersys and Alnylam - Press Releases

Amgen, Inc. Earnings: 4 Things You Probably Overlooked

Amgen delivered another solid earnings beat in the first quarter, but if you just skimmed the headlines you probably missed these four important points.

Is Amgen Inc.'s Dividend Sustainable?

Looking for income growth stocks? You need to look beyond the numbers.

Amgen Reports An Upbeat Q1 Earnings

Amgen: Growth Is Accelerating

See More AMGN News...

AMGN's Top Competitors

AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
CELG $118.71 (2.26%)
Current stock: CELG
$0.00 (0.00%)
Current stock: